Effectiveness of a Patient-Tailored, Pharmacist-Led Intervention Program to Enhance Adherence to Antihypertensive Medication: The CATI Study
Open Access
- 26 September 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 9, 1057
Abstract
Introduction: Non-adherence to medication is a complex health care problem. In spite of substantial efforts, up till now little progress has been made to effectively tackle the problem with adherence-enhancing interventions. The aim of this study was to investigate the effectiveness of a patient-tailored, pharmacist-led and theory-driven intervention program aimed to enhance self-reported adherence to antihypertensive medication. Materials and Methods: A parallel-group randomized controlled trial in 20 community pharmacies with nine months follow-up was conducted. Patients (45–75 years) using antihypertensive medication and considered non-adherent based on both pharmacy dispensing data and a self-report questionnaire were eligible to participate. The intervention program consisted of two consultations with the pharmacist to identify participants’ barriers to adhere to medication and to counsel participants in overcoming these barriers. The primary outcome was self-reported medication adherence. Secondary outcomes were beliefs about medicines, illness perceptions, quality of life and blood pressure. Mixed-model and generalized estimating equation (GEE) analyses were used to assess overall effects of the intervention program and effects per time point. Results: 170 patients were included. No significant differences between intervention and control groups were found in self-reported adherence, quality of life, illness perceptions, beliefs about medicines (concern scale), and blood pressure. After nine months, intervention participants had significantly stronger beliefs about the necessity of using their medicines as compared to control participants (mean difference 1.25 [95% CI: 0.27 to 2.24], p = 0.012). Discussion: We do not recommend to implement the intervention program in the current form for this study population. Future studies should focus on how to select eligible patient groups with appropriate measures in order to effectively target adherence-enhancing interventions. Trial Register: NTR5017 http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=5017.Keywords
This publication has 48 references indexed in Scilit:
- The association between patients’ beliefs about medicines and adherence to drug treatment after stroke: a cross-sectional questionnaire surveyBMJ Open, 2013
- Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest GroupValue in Health, 2013
- A new taxonomy for describing and defining adherence to medicationsBritish Journal of Clinical Pharmacology, 2012
- Psychometric Properties of Three Medication Adherence Scales in Patients With Rheumatoid ArthritisJournal of Nursing Measurement, 2012
- Effects of eHealth Interventions on Medication Adherence: A Systematic Review of the LiteratureJournal of Medical Internet Research, 2011
- Meta-AnalysisCirculation, 2011
- Pharmacist intervention program to enhance hypertension control: a randomised controlled trialInternational Journal of Clinical Pharmacy, 2011
- Patient adherence to medical treatment: a review of reviewsBMC Health Services Research, 2007
- The Common-Sense Model of Illness Representation: Theoretical and Practical ConsiderationsJournal of Social Distress and Homelessness, 1996
- Illness cognition: Using common sense to understand treatment adherence and affect cognition interactionsCognitive Therapy and Research, 1992